CTRI/2021/09/036560
Completed
Phase 4
A Clinical Study to assess the safety and efficacy of kanaka taila for its anti wrinkle and skin brightening effect in healthy volunteers - KT2021
Ms Ozone Pharmaceuticals Ltd0 sites50 target enrollmentTBD
Overview
- Phase
- Phase 4
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Ms Ozone Pharmaceuticals Ltd
- Enrollment
- 50
- Status
- Completed
- Last Updated
- 3 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Volunteers meeting the following criteria will be enrolled:
- •Ã¯â??· Between the age of 18\-65 years;
- •Ã¯â??· Available for 3 study visits;
- •Ã¯â??· Fine lines/wrinkles: Allergen fine lines (ââ?°Â¥ grade 1\)
- •Ã¯â??· Individuals who are willing to provide written informed consent
- •Ã¯â??· Individuals willing not to wear makeup or use skin care products other
- •than the study products the day of the study visits;
- •Ã¯â??· Individuals willing to discontinue using current skincare products and
- •only use study products for the study duration.
- •Ã¯â??· Individuals willing to refrain from sun tanning / sun bathing for the study
Exclusion Criteria
- •Volunteers will be excluded from the study if they meet any of the criteria listed
- •Ã¯â??· Any medically diagnosed chronic skin problems on their face (e.g.,
- •psoriasis, eczema, seborrheic dermatitis, or chronic cystic acne, etc.)
- •Ã¯â??· Diagnosed with known allergies to facial skin care products
- •Ã¯â??· Have undergone dermatological skin rejuvenation procedures such as
- •light\-therapies (lasers, radiofrequency and other lights treatments ) or
- •such as collagen or other facial tissue augmentation, fillers, or retail
- •micro dermabrasion on the face within the last 1 year preceding the
- •baseline visit and intended to receive them during the study period
- •Ã¯â??· Have planned surgeries or invasive procedures during the course of the
Outcomes
Primary Outcomes
Not specified
Similar Trials
Active, not recruiting
Phase 3
A Clinical Study to Evaluate the Safety and Efficacy of Livercure Tablets on Patients with Liver Cirrhosis.Health Condition 1: K745- Biliary cirrhosis, unspecifiedHealth Condition 2: K745- Biliary cirrhosis, unspecifiedCTRI/2022/07/043725Jammi Pharmaceuticals Pvt Ltd
Completed
Phase 2
Clinical study to evaluate the safety and efficacy of cinnamon in the management of non-alcoholic fatty liver diseaseHealth Condition 1: K760- Fatty (change of) liver, not elsewhere classifiedCTRI/2021/03/032039Central council for research in Unani medicine New dehli60
Completed
Not Applicable
To study the effect of Tab HFO-O2 in fatty individuals.CTRI/2016/07/007067Baidyanath Bhavan Pvt Ltd
Recruiting
Phase 2
Clinical study to evaluate the safety and efficacy of Lunagel 2.5 dermal fillerIRCT20190210042676N33ikan Teb Kimia CO30
Not yet recruiting
Not Applicable
A clinical trial of Malbet capsules in adult patients with uncomplicated influenza.Health Condition 1: J118- Influenza due to unidentified influenza virus with other manifestationsCTRI/2023/10/058885Solar Herbo Pvt. Ltd.